At the CES Unveiled event in New York City today, Tivic Health’s ClearUP® Sinus Pain Relief was selected as a CES 2020 Innovation Awards Honoree. The CES Innovation Awards recognizes companies for their innovations in engineering, design and technology. ClearUP Sinus Pain Relief was in good company with many notable honorees including P&G, Stanley Healthcare (BLACK+DECKER™), Garmin, Omron Healthcare, among others. ClearUP is a drug-free, non-invasive device that uses microcurrent (low-level electrical stimulation) to treat sinus pain from seasonal and year-round allergies. The ClearUP device is an example of bioelectronic medicine, an emerging trend in healthcare, with promising results for previously untreatable medical conditions, or chronic diseases.<1> “Our team is honored that ClearUP has been selected as a CES 2020 Innovation Awards Honoree. ClearUP’s use of drug-free, non-invasive microcurrent technology is disrupting how clinicians and consumers treat allergy-related sinus pain,” said Jennifer Ernst, CEO of Tivic Health. We are developing well-designed, accessible home-use bioelectronic medical devices for those suffering from a wide range of chronic conditions. We expect to bring more of these products to market giving millions access to health solutions that historically were treated with pharmaceuticals or even surgery.” <1> “Why It’s Time to Take Electrified Medicine Seriously”, TIME, October 24, 2019, https://time.com/5709245/bioelectronic-medicine-treatments/